Luminal and estrogen-responsive breast cancers express low levels of AP-1 [23, 48] and appear to respond to TGFβ only weakly; however, not all mesenchymal breast cancers express high levels of p63. This evidence concerns the gene TGFB1 and breast carcinoma.